Pharmaids Pharmaceuticals

65.00
0.00
(0.00%)
Market Cap
229.20 Cr
EPS
-3.56
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
87.46
52 Week Low
31.90
PB Ratio
3.41
Debt to Equity
0.09
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,841.60
#1 4,28,857.10
36.35
#1 49,887.20
12.06
#1 9,648
13.77
65.22
6,026.50
1,59,613.00
77.18
8,184.00
0.89
1,600
#1 64.53
58.36
1,555.10
1,23,234.00
24.69
26,520.70
14.17
4,155
47.38
61.58
3,335.00
1,09,619.10
58.81
10,785.70
11.59
1,656
13.54
60.05
2,560.40
1,05,517.00
51.57
10,615.60
19.57
1,942
-16.38
60.20
1,198.70
98,031.80
#1 18.23
28,905.40
12.36
5,578
1.69
59.17
2,105.40
92,203.00
32.12
20,141.50
#1 19.94
1,936
38.82
56.52
886.55
86,500.90
19.07
19,831.50
13.82
3,831
29.92
52.49
1,247.20
70,863.60
20.06
29,559.20
17.55
3,169
-10.04
61.96
29,780.00
63,121.10
47.37
6,097.20
10.80
1,201
16.01
46.72
Growth Rate
Revenue Growth
15.99 %
Net Income Growth
55.26 %
Cash Flow Change
-164.18 %
ROE
-50.06 %
ROCE
-60.05 %
EBITDA Margin (Avg.)
-

Quarterly Financial Results

Quarterly Financials
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
0
0
0
0
0
0
-0
1
6
5
5
5
Expenses
0
1
1
9
2
2
1
3
11
8
8
8
EBITDA
-0
-1
-1
-9
-1
-1
-1
-2
-6
-4
-3
-3
Operating Profit %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
-12,200 %
-96 %
-75 %
-50 %
-62 %
Depreciation
0
0
0
0
0
0
0
0
1
1
1
1
Interest
0
0
0
0
0
0
0
0
1
0
0
1
Profit Before Tax
-0
-1
-1
-9
-1
-1
-1
-2
-7
-4
-4
-4
Tax
0
0
0
-2
0
0
-1
-1
-1
-1
-1
-1
Net Profit
-0
-1
-1
-6
-1
-1
-1
-1
-6
-3
-3
-3
EPS in ₹
0.00
-0.05
-0.54
-4.76
-0.61
-0.61
-0.24
-0.54
-2.82
-0.76
-0.73
-0.55

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
11
25
91
Fixed Assets
0
0
63
Current Assets
3
18
14
Capital Work in Progress
0
2
7
Investments
0
3
0
Other Assets
11
19
21
Total Liabilities
11
25
91
Current Liabilities
2
2
12
Non Current Liabilities
0
0
9
Total Equity
9
23
71
Reserve & Surplus
-2
1
37
Share Capital
10
21
35

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
0
12
-8
Investing Activities
1
-5
-75
Operating Activities
-0
-4
-11
Financing Activities
0
21
78

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Jan 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
65.81 %
65.80 %
65.65 %
55.56 %
35.44 %
20.70 %
21.08 %
16.54 %
16.45 %
9.95 %
9.94 %
9.70 %
9.25 %
5.64 %
5.64 %
5.56 %
5.19 %
5.22 %
5.22 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
33.44 %
33.19 %
33.70 %
43.47 %
63.98 %
78.72 %
74.07 %
69.78 %
69.87 %
81.71 %
81.27 %
81.93 %
60.78 %
41.06 %
41.06 %
41.14 %
41.03 %
36.42 %
36.59 %
Others
0.74 %
1.01 %
0.65 %
0.97 %
0.58 %
0.57 %
4.84 %
13.68 %
13.68 %
8.34 %
8.79 %
8.37 %
29.96 %
53.30 %
53.30 %
53.29 %
53.78 %
58.37 %
58.20 %
No of Share Holders
5,861
7,192
7,331
8,314
9,620
9,495
9,193
8,862
8,196
7,761
7,476
7,393
7,281
7,554
7,567
7,594
8,050
8,349
8,220

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Intimation Of Loan AgreementMar 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 26, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 26, 2025
Closure of Trading WindowMar 25, 2025
Intimation Under Regulation 8(2) Of SEBI (PIT) Regulation 2015 Regarding Amendment In Fair Disclosure CodeMar 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 20, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 19, 2025
Announcement Under Regulation 30 (LODR)- Intimation On Loan AgreementFeb 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationFeb 12, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 12, 2025
Integrated Filing (Financial)Feb 12, 2025
Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 12, 2025
Board Meeting Outcome for For Declaration Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024Feb 12, 2025
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024.Feb 07, 2025
Outcome Of The Circular Resolution Passed By The Board Of Directors Of The Company On February 06 2025Feb 06, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionFeb 05, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJan 10, 2025
Draft Letter of OfferJan 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJan 03, 2025
Detailed Public StatementJan 03, 2025
Announcement Under Regulation 30 - Intimation For Execution Of Share Purchase AgreementDec 27, 2024
Announcement under Regulation 30 (LODR)-Public Announcement-Open OfferDec 27, 2024
Public Announcement - Open OfferDec 27, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 23, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 17, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 16, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 12, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 11, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 09, 2024
Intimation Of Receipt Of National GLP Certification For Material Subsidiary Of The Company.Dec 09, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 06, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 05, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 03, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 02, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Nov 28, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2024
Announcement Under Regulation 30 - Contact Details Of KMP For Determining Materiality Of Event/ Information And Making Disclosure.Nov 13, 2024
Financial Results For The Quarter And Half Year Ended September 30, 2024Nov 13, 2024
Board Meeting Outcome for Board Meeting Outcome For Declaration Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2024.Nov 13, 2024
Announcement Under Regulation 30 (LODR) - Intimation On Loan Agreement.Nov 09, 2024
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2024.Nov 07, 2024
Announcement Under Regulation 30 Of SEBI (LODR) Regulation 2015 - Clarification On Price Movement.Nov 04, 2024
Clarification sought from Pharmaids Pharmaceuticals LtdNov 04, 2024
Announcement Under Regulation 30 (LODR) - Intimation On Loan Agreement.Oct 30, 2024
Announcement under Regulation 30 (LODR)-Updates on AcquisitionOct 30, 2024

Technical Indicators

RSI(14)
Neutral
43.51
ATR(14)
Less Volatile
3.96
STOCH(9,6)
Neutral
38.35
STOCH RSI(14)
Neutral
29.09
MACD(12,26)
Bearish
-0.13
ADX(14)
Weak Trend
13.14
UO(9)
Bearish
37.29
ROC(12)
Downtrend And Accelerating
0.00
WillR(14)
Neutral
-69.20